Results 41 to 50 of about 1,014,756 (299)

Other title: Kansas Housing Resources Corporation press releases, 2020; Other title: Kansas Housing Resources Corporation news releases, 2013

open access: yes, 2020
Kansas Housing awards $2.3 million for rural housing development -- In search of a fresh start, and dignity -- Alissa Ice named Director of Housing Development -- Addressing the Need: 2019 Annual Report -- Kansas Housing awards $150,000 to support ...
Kansas Housing Resources Corporation.
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Integration of Photovoltaic Systems for Energy Self-Sufficient Low-Rise Multi-Family Residential Buildings in Republic of Korea

open access: yesBuildings
Globally, building energy consumption has been rising, emphasizing the need to reduce energy usage in the building sector to lower national energy consumption and carbon dioxide emissions.
Byung Chang Kwag   +2 more
doaj   +1 more source

Investigation into Common Decay of Educational Buildings in Malaysia

open access: yesMATEC Web of Conferences, 2014
All types of buildings will undergo decay and deterioration over a period of time. In the past few years, there have been numerous official reports in the mass media relating to building decay and failures throughout the country.
Tan S.W.   +3 more
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Other title: Kansas Housing Resources Corporation press releases, 2008; Other title: Kansas Housing Resources Corporation news releases, 2008

open access: yes, 2008
PUT THE TIME PERIOD COVERED HERE... e.g. January-December 2003; application/pdf; Annual cumulation of 2008 issuesKansas Housing Awards $1.9 Million to Rehab Unsafe Homes -- 108 Affordable Housing Units Planned for Coffeyville -- 3.2 Million in Federal ...
Kansas Housing Resources Corporation.
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Fire retardant treatment of low contamination for panels made from recycled plastic films and polyester resin

open access: yesCogent Engineering, 2017
The aim of this research was to propose a fire retardant treatment with low contamination additives for panels manufactured with recycled plastics from packaging of food industries and polyester resin.
Gaggino Rosana, Kreiker Jerónimo
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy